Nasser Al-Qahtani
Saudi FDA: Working with Industry to Improve the Reporting of Adverse Reactions
December 13 by Andrea CharlesIn this interview Dr. Nasser Al-Qahtani, Head, Adverse Drug Reactions Evaluation Department Saudi FDA speaks to Andrea Charles from Pharma IQ, about the Saudi FDA pharmacovigilance system and wha...